Protara Therapeutics Inc

The current institutional shareholding score of Protara Therapeutics Inc is 7.00, ranking 80 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 85.08%, representing a quarter-over-quarter increase of 61.63%. The largest institutional shareholder is Steven Cohen, holding a total of 1.26M shares, representing 2.09% of shares outstanding, with 1.91% increase in holdings.